8-KEarnings & ResultsExhibits & Filings

BIOGEN INC. 8-K Report, Financial Results (Nov 8, 2023)

Filed November 8, 2023For Securities:BIIB

Summary

Biogen Inc. (BIIB) filed an 8-K on November 8, 2023, primarily to furnish its press release announcing third-quarter 2023 results. While the filing itself contains minimal new information beyond the announcement of the press release, investors should refer to the furnished press release (Exhibit 99.1) for detailed financial and operational performance updates. This filing serves as the official notification of the release of these results.

Key Highlights

  • 1Biogen Inc. announced its third-quarter 2023 results of operations and financial condition.
  • 2The official announcement was made via a press release dated November 8, 2023.
  • 3The press release is furnished as Exhibit 99.1 to the 8-K filing.
  • 4This filing does not contain the full financial statements or detailed operational data; these are contained within the referenced press release.
  • 5The information provided is furnished and not deemed 'filed' for certain regulatory purposes.
  • 6Investors are directed to the press release for comprehensive Q3 2023 performance details.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce that Biogen Inc. has released its third-quarter 2023 financial results and operational performance through a press release.

The detailed financial results for the third quarter ended September 30, 2023, are contained within the press release furnished as Exhibit 99.1 to this 8-K filing. Investors should review that document for specific performance figures, revenue breakdowns, and other financial metrics.

No, this 8-K filing itself does not contain new financial statements. It only refers to and incorporates by reference the press release issued by Biogen that details the Q3 2023 results.

When information is 'furnished' under Item 2.02, it means it's being publicly disclosed via the 8-K but is not subject to the same liabilities as if it were 'filed' under Section 18 of the Exchange Act. Essentially, it's a disclosure mechanism without the full legal implications of a formal filing for that specific information.